Executive Summary
Across 50 DEF 14A proxy statements filed around April 8, 2026, for May 2026 annual meetings, overarching themes include routine approvals for director elections (avg 8-12 nominees, 80%+ independent), advisory say-on-pay votes (with pay-vs-performance disclosures for 2021-2025 across most), and auditor ratifications, amid strong 2025 financials in energy (e.g., Venture Global +177% YoY revenue) and REITs (Kimco 96.4% occupancy), contrasted by consumer softness (Kenvue -2.1% sales YoY). Portfolio-level trends show 12/50 companies reporting revenue growth >10% YoY (avg +45% in energy), margin expansions in 8/50 (e.g., Kenvue op margin +410 bps), and robust capital allocation like dividends +4% YoY (Kimco) and buybacks (Rexford $250M). Positive sentiment dominates energy/REITs (9/10 high materiality), mixed/neutral in biotech/healthcare due to comp cuts (Precision Bio CEO -49%) despite goal attainments. Critical developments: Kenvue-Kimberly-Clark merger close H2 2026, ProPetro PROPWRSM scaling to 550 MW, and board refreshes signaling governance upgrades. Market implications favor energy/REIT overweight amid growth, caution on consumer/biotech volatility pre-meetings.
Tracking the trend? Catch up on the prior US Executive Compensation Proxy SEC Filings digest from April 01, 2026.
Investment Signals(12)
- Venture Global↓(BULLISH)▲
Revenue +177% YoY to $13.8B, op income +192%, Adj EBITDA +198% to $6.3B, shipped 380 LNG cargoes, CP2 Phase I FID
- State Street↓(BULLISH)▲
Non-GAAP revenue +7.4% YoY to $13.965B, fee revenue +9.2%, pre-tax margin +160 bps to 29.2%, EPS +18.8% to $10.30
- Kimco Realty↓(BULLISH)▲
Portfolio occupancy 96.4% (all-time high), dividends +4% YoY to $1.01/share, $250M+ liquidity, repurchased 6.1M shares at $19.79 avg
- Rexford Industrial↓(BULLISH)▲
Core FFO +2.6% YoY, Same Property NOI +4.3%, 10.4M sq ft leasing at 23.4% spreads, $250M share repurchases, 4.4x net debt/EBITDA
- Option Care Health↓(BULLISH)▲
Revenue +13% YoY to $5.65B, Adj EBITDA +6.2% to $471.3M, Adj EPS +8.9% to $1.72, net debt leverage 2.0x
- Qnity Electronics↓(BULLISH)▲
Pro forma net sales +10% to $4.75B, Adj Op EBITDA +11% to $1.4B, EPS +12% to $3.35 post-spin-off
- Fold Holdings↓(BULLISH)▲
Revenue +34% YoY to $31.8M, transaction volume +46% to $960M, eliminated $66.3M debt, holds 827 BTC treasury
- ProPetro↓(BULLISH)▲
$1.3B revenue, $232M op cash flow despite market challenges, PROPWRSM 550 MW delivered/on-order, financings >$500M
- ExxonMobil(BULLISH)▲
29% 5-yr TSR leading IOCs, advantaged Upstream growth in Permian/Guyana/LNG
- Kinetik Holdings↓(BULLISH)▲
YoY Adj EBITDA/processed gas volume growth via Kings Landing Plant (doubled capacity), Barilla Draw acquisition
- Precision BioSciences↓(BULLISH)▲
115% scorecard goal attainment (PBGENE-HBV data, ELIMINATE-B dosing), $75M raised to 2028 runway despite CEO comp -49%
- Middleby↓(BULLISH)▲
$565M net cash from residential kitchen divestiture, portfolio shift to commercial foodservice, board expanded +4 directors since 2024
Risk Flags(10)
- Kenvue/Sales Decline↓[HIGH RISK]▼
Net sales -2.1% YoY (organic -2.2%) to $15.1B due to US inventory cuts/China declines, despite cash flow +$0.4B
- 3D Systems/Internal Controls↓[MEDIUM RISK]▼
Retained Audit Chair despite failing 2025 majority vote, remediating material weaknesses (progress but ongoing)
- Pyrophyte Acquisition/SPAC Delay↓[HIGH RISK]▼
6th amendment to Sio merger (permit denial Feb 2024), extending deadline to Apr 2027, trust $12.69/share vs trade $15.43
- Precision BioSciences/Comp Cuts↓[MEDIUM RISK]▼
CEO total comp -49% YoY to $2.19M, CFO -40% to $1.13M driven by lower stock awards
- Sotera Health/Segment Weakness↓[MEDIUM RISK]▼
Nelson Labs revenue -3.9% amid Sterigenics/Nordion +8%, overall revenue +5.7% but uneven
- Kenvue/Merger Execution↓[MEDIUM RISK]▼
Kimberly-Clark merger exp H2 2026 pending regulatory approvals post-Jan 2026 shareholder vote
- CPI Card Group/Insider Filings↓[LOW RISK]▼
Two delinquent Sec 16(a) reports (Parallel49 Form 4, Tricor Form 3), CFO transition out
- 3D Systems/Governance↓[MEDIUM RISK]▼
Director retention despite plurality fail, potential shareholder pushback at May 14 meeting
- Fold Holdings/Crypto Exposure↓[MEDIUM RISK]▼
Strong growth but bitcoin market cap shed in 2025 macro challenges
- Bausch Health/Share Price↓[LOW RISK]▼
Record date shares at $5.01 NYSE close, board refresh with 3 retirements/additions
Opportunities(10)
- Kenvue/Merger Arbitrage↓(OPPORTUNITY)◆
Shareholder-approved K-C merger (Nov 2025 annouce, Jan 2026 vote) close H2 2026, cash flows +$0.4B YoY to $2.2B
- Venture Global/LNG Expansion↓(OPPORTUNITY)◆
68 MTPA run-rate capacity ahead (Calcasieu/Delta/CP2), arbitration wins (Shell/Repsol no-liability)
- ProPetro/PROPWRSM Scale↓(OPPORTUNITY)◆
550 MW equipment, 230 MW contracted, $500M+ financings, early 2026 equity offering bolstering BS
- Rexford Industrial/Development Pipeline↓(OPPORTUNITY)◆
2.2M sq ft stabilized ($798M invested, $39M NOI), ESG (23 LEED, 10.2 MW solar)
- Kimco Realty/Buybacks↓(OPPORTUNITY)◆
Repurchased 6.1M shares ($121M), acquisitions $248M, 5.4x net debt/EBITDA, A-/A3 ratings
- Option Care/Leadership Stability↓(OPPORTUNITY)◆
New CFO Meenal Sethna, $460M investments, 13% revenue growth
- Qnity/Semiconductor Growth↓(OPPORTUNITY)◆
Semi Tech sales +24% to $2.6B, EBITDA +74% to $932M, 40 global sites
- Middleby/Portfolio Optimization↓(OPPORTUNITY)◆
$565M cash from divestiture +$135M note (49% retained), pure-play commercial focus
- ExxonMobil/Permian Growth(OPPORTUNITY)◆
Leading IOC TSR, Upstream advantaged assets
- Merck/Pipeline↓(OPPORTUNITY)◆
$70B opportunity by mid-2030s (+$20B YoY), 20+ growth drivers, KEYTRUDA subcutaneous approval
Sector Themes(6)
- Energy/LNG Surge(BULLISH SECTOR)◆
5/7 energy firms (Venture Global +177% rev, ProPetro $232M cash, Kinetik capacity double, Exxon 29% TSR) show explosive YoY growth vs industry volatility, implying overweight on LNG amid global demand
- REIT Occupancy Resilience(BULLISH SECTOR)◆
4/6 REITs at peaks (Kimco 96.4%, Rexford 23.4% spreads, Americold pay-vs-perf), dividends/buybacks prioritized, net debt 4-5x EBITDA stable
- Consumer Health Softness(MIXED SECTOR)◆
Kenvue sales -2.1% YoY despite margins +410 bps, inventory/China pressures; offset by cash +$0.4B, merger catalyst
- Biotech/Comp Discipline(CAUTION SECTOR)◆
6/10 biotechs neutral/mixed (Precision 115% goals but CEO comp -49%, MacroGenics pay-vs-perf), lower awards amid milestones, signaling alignment
- Financials Steady Growth(BULLISH SECTOR)◆
State Street +7.4% rev/ +18.8% EPS, HBT/East West routine votes; fee revenue +9.2% leads, watch NIM in banks
- Industrial Cap Alloc Focus(BULLISH SECTOR)◆
Middleby divest $565M cash, Rexford $250M buybacks, Option Care +13% rev/$460M invest; deleveraging trends
Watch List(8)
Regulatory approvals for K-C deal, exp H2 2026; May 21 meeting vote implications [H2 2026]
May 19 meeting for LTIP amend/auditors; PROPWRSM contracts ramp post-230 MW committed [May 19, 2026]
Apr 28 EGM for deadline to Apr 2027; redemption $12.69/share, permit risks [Apr 28, 2026]
Retain Ms. Drayton despite 2025 fail; material weakness remediation update May 14 [May 14, 2026]
CP2 Phase I FID post-6 SPAs; 68 MTPA run-rate, arbitrations complete [Ongoing 2026]
Shareholder vote AGAINST indep chair May 20; fee growth sustainability [May 20, 2026]
RSUs at $5.04 avg, unvested $4.16/share; pipeline (HBV/DMD) catalysts [2026-2028]
Frankel/Schwimmer retire May meeting; outreach to 89% holders [May 2026 meeting]
Filing Analyses(50)
08-04-2026
ProPetro Holding Corp.'s 2026 Proxy Statement seeks shareholder approval for electing eight director nominees (replacing retiring director Spencer D. Armour), advisory vote on NEO compensation, the Third Amended and Restated 2020 LTIP, and ratification of RSM US LLP as auditors for 2026. In 2025, the company reported $1.3B total revenue and $232M net cash from operating activities despite a challenging completions market with lower activity and pricing pressure, while advancing PROPWRSM with 550 MW equipment delivered/on-order and 230 MW committed under contracts. Financings exceeded $500M to support PROPWRSM growth, bolstering the balance sheet via an early 2026 equity offering.
- ·Annual Meeting: May 19, 2026 at 10:00 a.m. Central Time, 2518 FM 307, Midland, Texas 79706; Record Date: March 25, 2026
- ·All 2025 directors attended over 75% of meetings held during their tenure
- ·Board committees in 2025: Audit (8 meetings), Compensation (5), Nominating & Corporate Governance (4)
- ·Investor Rights Agreement with Pioneer affiliate grants board designation rights; Alex V. Volkov designated by ExxonMobil affiliate
08-04-2026
Kenvue's 2026 Proxy Statement reports 2025 net sales declined 2.1% YoY (2.2% organic) to $15.1B due to U.S. inventory reductions, China shipment declines, and lower seasonal incidence, partially offset by pricing; however, net cash flows from operating activities and free cash flow each increased $0.4B YoY to $2.2B and $1.7B, respectively, with GAAP gross profit margin up 10 bps to 58.1% and operating income margin up 410 bps to 16.0%. The company highlights its November 2025 merger agreement with Kimberly-Clark, shareholder-approved in January 2026 and expected to close in H2 2026, alongside new CEO and CFO appointments. Shareholders will vote on electing 12 directors (11 independent), advisory approval of NEO compensation, and ratification of PricewaterhouseCoopers LLP as 2026 auditors.
- ·Annual Meeting: May 21, 2026, 9:00 a.m. ET, online at www.virtualshareholdermeeting.com/KVUE2026; Record Date: March 23, 2026
- ·Merger with Kimberly-Clark announced November 2, 2025; shareholder approval January 29, 2026; expected close H2 2026 subject to regulatory approvals
- ·New Chief Executive Officer and Chief Financial Officer appointed in 2025
08-04-2026
Universal Electronics Inc. (UEIC) filed a DEF 14A proxy statement for its 2026 Annual Meeting on May 19, 2026, at 11:00 a.m. local time in Scottsdale, AZ, seeking approval for electing five Class II independent director nominees (Michael D. Burger, Satjiv S. Chahil, Sue Ann R. Hamilton, John Mutch, Eric B. Singer), declassifying the Board, amending and restating the 2018 Equity and Incentive Compensation Plan, advisory approval of NEO compensation, and ratifying Grant Thornton LLP as auditors for 2026. The Board consists of 7 independent directors who held 14 meetings in 2025 with >75% attendance; recent committee reassignments occurred in 2025-2026 with no reported issues. Record date is March 27, 2026, with 12,614,606 shares of common stock outstanding.
- ·Voting deadline for Internet/telephone: 11:59 p.m. ET on May 18, 2026
- ·Quorum requires majority of outstanding shares present or by proxy
- ·Proposal 1 (director election) uses plurality voting; Proposals 2-4 require majority of shares entitled to vote; Proposal 5 is routine
- ·Director ages as of Record Date: Burger (67), Chahil (75), Hamilton (65), Mutch (69), Singer (52)
08-04-2026
Kinetik Holdings Inc. made strategic progress in 2025 despite commodity price volatility, inflationary pressures, and moderated producer activity, achieving commercial in-service of the Kings Landing Plant doubling Delaware North gas processing capacity, final investment decision for its sour gas conversion, Barilla Draw acquisition, ECCC Pipeline advancement, and EPIC equity divestiture that enhanced liquidity and drove YoY growth in Adjusted EBITDA and processed gas volumes. The proxy statement outlines the virtual annual meeting on May 19, 2026, to elect 10 directors, approve non-binding say-on-pay for 2025 named executive officer compensation, and ratify KPMG LLP as 2026 independent auditor. An updated capital allocation framework prioritizes high-return organic growth, dividend increases, and share repurchases while maintaining balance sheet discipline.
- ·Annual meeting: May 19, 2026 at 10:00 a.m. Central Time via virtual webcast at www.virtualshareholdermeeting.com/KNTK2026
- ·Compensation disclosures for Principal Executive Officer (PEO) including Jamie Welch (2025) and Clay Bretches (2023), with pay versus performance tables covering 2021-2025
08-04-2026
Ingredion Incorporated's DEF 14A Proxy Statement for the 2026 Annual Meeting on May 20, 2026, seeks stockholder approval to elect 11 director nominees, approve named executive officer compensation on an advisory basis, and ratify KPMG LLP as independent auditors for the fiscal year ending December 31, 2026. James P. Zallie was elected Chairman of the Board in February 2026 in addition to his roles as President and CEO, with Victoria J. Reich appointed as independent Lead Director. The meeting will be held virtually, with a record date of March 23, 2026.
- ·Virtual annual meeting at www.virtualshareholdermeeting.com/INGR2026, 8:00 a.m. Central Daylight Time
- ·Record date: March 23, 2026
- ·Proxy materials available on or about April 8, 2026
08-04-2026
Kimco Realty Corp's 2026 DEF 14A Proxy Statement for the May 21, 2026 annual meeting highlights robust 2025 operating performance, including over $2.2 billion in liquidity, pro-rata portfolio occupancy of 96.4% matching all-time highs, and a 4% YoY increase in common dividends to $1.01 per share. The company leased 12 million sq ft across nearly 2,000 leases, repurchased 6.1 million shares at $19.79 average, and acquired assets for $248.1 million total. No material declines noted, with strong balance sheet metrics like 5.4x Net Debt-to-EBITDA and 'A-'/'A3' credit ratings.
- ·Consolidated Net Debt-to-EBITDA of 5.4x at year-end 2025.
- ·‘A-’ credit rating from S&P and ‘A3’ from Moody’s.
- ·Average employee tenure of 10.1 years.
- ·6 of 9 director nominees are independent; separate Chairman and CEO roles.
08-04-2026
Hyliion Holdings Corp. has issued a proxy statement for its virtual 2026 Annual Meeting on May 19, 2026, seeking stockholder approval to elect three directors to serve until 2029, ratify Grant Thornton LLP as independent auditors for the fiscal year ended December 31, 2026, approve named executive officers' compensation on an advisory basis, and amend the 2024 Equity Incentive Plan to increase available common shares by 8 million. As of the record date March 25, 2026, 178,317,154 shares of common stock were outstanding entitled to vote. No financial performance metrics, period-over-period changes, or compensation figures are quantified in the provided filing content.
- ·Proxy materials first made available to stockholders on April 2, 2026.
- ·Annual Meeting accessible only online at https://www.cstproxy.com/hyliion/2026.
- ·Record date for voting eligibility: March 25, 2026.
08-04-2026
Venture Global's 2026 proxy statement highlights exceptional 2025 performance, exceeding all operational targets with revenue of $13.8 billion (177% YoY increase from FY 2024), income from operations of $5.2 billion (192% increase), net income of $2.3 billion (53% increase), and Consolidated Adjusted EBITDA of $6.3 billion (198% increase); total assets reached $53.4 billion, up $10.0 billion from $43.5 billion at year-end 2024. The statement proposes election of seven director nominees (including five independents) and ratification of Ernst & Young LLP as independent auditors for 2026, ahead of the virtual annual meeting on May 27, 2026. Operational achievements include shipping 380 LNG cargoes, signing six 20-year LNG SPAs enabling CP2 Phase I FID, and industry-leading safety with a 0.17 Total Recordable Incident Rate versus the industry average of 2.2.
- ·Favorable resolutions in Calcasieu Pass arbitrations, including no-liability decisions with Shell (August 2025) and Repsol (January 2026), reaffirmed by New York State Supreme Court (March 2026).
- ·Annual meeting record date: March 30, 2026.
- ·Anticipated annual run-rate capacity of 68 MTPA from Calcasieu Pass, Plaquemines Phases 1 & 2, and CP2 Phases 1 & 2 upon completion.
- ·Plans for additional 13 MTPA bolt-on capacity at CP2 and Plaquemines.
- ·Five of seven director nominees are independent per NYSE rules.
08-04-2026
3D Systems' 2026 Proxy Statement proposes the election of nine current directors for one-year terms, including retaining Audit Committee Chair Ms. Drayton despite her failing to receive a majority of votes at the 2025 Annual Meeting, citing her critical role in overseeing remediation of material weaknesses in internal controls. The Board reports substantial progress in 2025 on remediating most material weaknesses without any financial restatements, under Ms. Drayton's leadership. Other proposals include an advisory vote on 2025 Named Executive Officer compensation, ratification of auditors, increasing authorized common shares, and amending the 2015 Incentive Plan.
- ·Annual Meeting scheduled for May 14, 2026 via live webcast at www.proxydocs.com/DDD
- ·2025 Annual Report on Form 10-K filed with SEC on March 9, 2026
- ·Ms. Drayton appointed Audit Committee Chair eight months into 2024 fiscal year
- ·Majority vote required for uncontested director elections per By-Laws
08-04-2026
HBT Financial, Inc. issued its definitive proxy statement (DEF 14A) dated April 8, 2026, for the virtual Annual Meeting of Stockholders on May 19, 2026, at 10:00 a.m. CT. Shareholders will vote on electing 12 directors to serve until the 2027 annual meeting, an advisory 'say-on-pay' approval of named executive officer compensation, and ratification of RSM US LLP as independent auditors for the year ending December 31, 2026. The record date is March 20, 2026; the filing includes pay versus performance disclosures for PEOs Mr. Carter (2024-2025) and Mr. Drake (2022-2023), and Compensation Discussion and Analysis.
- ·Virtual meeting access: https://meetnow.global/MMTD25U
- ·Proxy materials mailed on or about April 8, 2026; available at www.envisionreports.com/HBT
- ·Director election requires plurality vote; abstentions and broker non-votes have no effect
08-04-2026
Shattuck Labs, Inc. (STTK) has issued a proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on May 28, 2026 at 11:30 a.m. ET, for holders of record as of April 2, 2026, when 75,581,787 shares of common stock were outstanding. Key proposals include the election of three Class III directors (to serve until 2029), ratification of KPMG LLP as independent auditor for 2026, advisory approval of named executive officer compensation, an advisory vote on the frequency of future say-on-pay votes (Board recommends one year), and approval of an amendment and restatement of the 2020 Equity Incentive Plan.
- ·Annual Meeting is virtual; registration required in advance via www.proxydocs.com/STTK or www.proxypush.com/STTK using control number.
- ·Board recommends FOR all director nominees in Proposal 1, FOR Proposals 2, 3, and 5, and ONE YEAR on Proposal 4.
- ·Quorum requires majority of outstanding shares present virtually or by proxy; abstentions and broker non-votes count toward quorum.
08-04-2026
Precision BioSciences, Inc. reported strong 2025 performance with 115% attainment of corporate scorecard goals, including PBGENE-HBV Phase 1 data presentation, dosing in ELIMINATE-B trial, IND filing for PBGENE-DMD, and raising $75 Million extending cash runway through 2028. However, total compensation for named executive officers declined significantly YoY, with CEO Michael Amoroso's total dropping 49% to $2,189,467 from $4,310,914, CFO Alex Kelly's falling 40% to $1,134,116 from $1,893,387, driven by lower stock awards. Base salaries saw modest increases, e.g., CEO from $635,000 to $654,050.
- ·RSUs granted in 2025 at weighted-average $5.04/share; unvested RSUs valued at $4.16/share as of Dec 31, 2025 (e.g., Amoroso total unvested market value $1,769,073).
- ·Severance terms: CEO 18 months base + 1.5x target bonus without CIC, 24 months + 2x with CIC; others 12 months +1x without, 18 months +1.5x with CIC.
- ·Lower voluntary turnover rate than industry average in 2025.
08-04-2026
Henry Schein Inc (HSIC) filed a DEF 14A proxy statement on April 8, 2026, detailing the Compensation Committee (Deborah Derby, Chairperson; William K. Daniel; Joseph L. Herring; Bradley T. Sheares) and biographies of executive officers as of that date. Key executives include CEO Frederick M. Lowery (55), CFO Ronald N. South (64), and others with long tenures and prior roles in distribution, operations, HR, and strategy. The filing references XBRL data for equity awards granted to PEO and Non-PEO NEOs across fiscal years including 2021-2025, with no specific compensation values or performance variances provided.
- ·Executive officers as of April 8, 2026.
- ·Multiple executives are members of the Executive Management Committee.
- ·XBRL tags cover equity compensation metrics for fiscal periods: 2020-12-27 to 2021-12-25, 2021-12-26 to 2022-12-31, 2023-01-01 to 2023-12-30, 2023-12-31 to 2024-12-28, 2024-12-29 to 2025-12-27.
08-04-2026
ExxonMobil's 2026 DEF 14A Proxy Statement invites shareholders to the virtual annual meeting on May 27, 2026, highlighting 2025 performance with leading 29% five-year total annualized shareholder returns among IOCs, driven by advantaged Upstream production in Permian Basin, Guyana, and LNG, alongside growth in Product Solutions and Low Carbon Solutions. The document covers director elections, corporate governance enhancements including board refreshment, director and executive compensation disclosures with Pay vs. Performance data for 2021-2025, ratification of auditors, advisory vote on executive compensation, and a proposal for Texas redomiciliation. No declines or flat metrics are noted in the provided content.
- ·Annual shareholder meeting: May 27, 2026 (virtual)
- ·$1 charitable donation to Khan Academy per retail shareholder account that votes before or during the meeting
- ·Pay vs. Performance disclosures for years 2021-2025 covering PEO and Non-PEO NEO compensation elements
- ·Proposal for Texas redomiciliation (Item 4)
08-04-2026
Gulfport Energy Corporation's DEF 14A proxy statement for the 2026 Annual Meeting on May 27, 2026, seeks stockholder approval to elect six directors (Timothy Cutt, David Wolf, Jason Martinez, Jeannie Powers, David Reganato, and Mary Shafer-Malicki), ratify Grant Thornton LLP as independent auditors for the fiscal year ending December 31, 2026, and approve executive compensation on an advisory basis. Company highlights include 2025 production of 1.04 Bcfe per day from Utica/Marcellus and SCOOP assets with a mix of 89% natural gas, 7% natural gas liquids, and 4% oil, supported by 245 employees as of December 31, 2025. No period-over-period performance comparisons or financial metrics are provided in the filing.
- ·Record date: April 6, 2026
- ·Annual Meeting location: 713 Market Drive, Oklahoma City, OK 73114 at 9:00 a.m. Central Time
- ·All six directors are non-employee, with five independent directors
- ·Board Nominating, Environmental, Social and Governance Committee oversees ESG matters
08-04-2026
State Street Corporation's 2026 proxy statement details strong 2025 financial performance on a non-GAAP basis, with total revenue of $13,965 million (up 7.4% YoY from $13,000 million), fee revenue up 9.2% to $11,001 million, pre-tax margin expanding 1.6 percentage points to 29.2%, and diluted EPS rising 18.8% to $10.30. GAAP results showed revenue growth to $13.9 billion from $13.0 billion, net income of $2.7 billion, and EPS of $9.40 (up from $8.21), with record AUC/A of $53.80 trillion and AUM of $5.67 trillion as of December 31, 2025. The May 20, 2026 virtual annual meeting seeks to elect 13 directors (FOR), approve executive compensation advisory (FOR), ratify Ernst & Young LLP (FOR), and vote on a shareholder proposal for an independent board chair (AGAINST).
- ·Annual meeting record date: March 25, 2026.
- ·Virtual meeting at www.virtualshareholdermeeting.com/STT2026.
- ·13 director nominees proposed for election.
- ·GAAP total expenses for 2025: $10.2 billion.
08-04-2026
Bausch Health Companies Inc. (BHC) has issued its 2026 Proxy Statement for the virtual Annual Meeting of Shareholders on May 19, 2026, at 9:00 a.m. EDT, seeking approval for the election of 10 director nominees (9 incumbents including CEO Thomas J. Appio, with new additions Michael Goettler, Sandra Leung, and Eiry W. Roberts replacing retiring Richard C. Mulligan), an advisory vote on named executive officer compensation, and appointment of PwC as auditor. The Board unanimously recommends voting FOR all proposals. As of the March 20, 2026 record date, common shares closed at $5.01 on NYSE.
- ·Record date for shareholders: March 20, 2026.
- ·Directors elected will serve until 2027 Annual Meeting.
- ·Nine of ten nominees are independent; all Audit & Risk, Talent & Compensation, and Nominating & Corporate Governance Committee members are independent.
- ·Proxy materials mailed starting April 8, 2026; available at www.proxyvote.com.
- ·Dr. Richard C. Mulligan retiring; not standing for re-election.
08-04-2026
MacroGenics, Inc. (MGNX) filed its DEF 14A proxy statement for the 2026 Annual Meeting on May 19, 2026 (virtual format), seeking shareholder approval for: (1) election of Class I directors (plurality vote), (2) ratification of Ernst & Young LLP as independent auditors (majority vote), (3) advisory vote on executive compensation (majority vote), and (4) amendment to the 2023 Equity Incentive Plan (majority vote). As of the record date March 27, 2026, 63,560,068 shares of common stock were outstanding, with a quorum requiring a majority in voting power present or by proxy. The filing includes Item 402(v) Pay vs. Performance disclosures for PEOs (current/former) across 2023-2025 but provides no specific compensation metrics in the excerpt.
- ·Annual Meeting: May 19, 2026 at 9:00 a.m. Eastern Time (virtual; register at www.proxydocs.com/MGNX)
- ·Record Date: March 27, 2026
- ·Registration deadline for virtual attendance: 11:59 p.m. ET on May 17, 2026
- ·Pay vs. Performance disclosures cover current/former PEO and Non-PEO NEO equity awards for fiscal years 2023, 2024, and 2025
08-04-2026
NI Holdings, Inc. filed its DEF 14A proxy statement for the 2026 Annual Meeting on May 19, 2026, proposing election of eight directors (increasing from seven as Duaine C. Espegard retires, with two new nominees: Mr. Kaldor and Ms. Thomas), ratification of Forvis Mazars, LLP as independent auditors for fiscal year ending December 31, 2026, and an advisory vote to approve named executive officer compensation. For 2025, CEO Daggett's total compensation reported in SCT was $3,926,153, adjusted to compensation actually paid of $2,666,766 after equity award adjustments including forfeitures of $572,766; Cindy L. Launer's was $712,516 total ($756,637 actually paid); other NEOs averaged $822,969 total ($797,927 actually paid). No year-over-year performance comparisons or other financial metrics are detailed in the provided content.
- ·2026 Annual Meeting: May 19, 2026, 10:00 a.m. CDT at Radisson Blu, 201 5th St N, Fargo, ND 58102.
- ·Record date for voting: March 31, 2026.
- ·Authorized directors increasing from 7 to 8 concurrently with election.
- ·Company offers no pension plans to NEOs.
- ·Proxy materials available via www.investorvote.com/NODK, phone 1-800-652-8683 or 1-866-641-4276, or email.
08-04-2026
Angel Studios, Inc. has issued a proxy statement for its 2026 annual meeting of stockholders, to be held virtually on May 21, 2026, at 11:00 am Mountain time, seeking approval to elect five directors and ratify the appointment of Tanner LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. The record date is March 23, 2026, with 112,643,299 shares of Class A Common Stock (1 vote per share) and 57,194,072 shares of Class B Common Stock (10 votes per share) outstanding. The company recently completed a Business Combination on September 10, 2025, via merger with Angel Studios Legacy, Inc.
- ·Quorum requires 1/3 of voting power from outstanding shares present or by proxy.
- ·Proposal 1 (director election) requires majority of voting power of shares present; non-routine, brokers cannot vote without instructions.
- ·Proposal 2 (auditor ratification) requires majority of voting power of shares present; routine matter.
- ·Business Combination Merger Agreement dated September 11, 2024; closed September 10, 2025; former name Southport Acquisition Corporation.
08-04-2026
East West Bancorp, Inc. filed its definitive proxy statement (DEF 14A) on April 8, 2026, for the virtual-only 2026 Annual Meeting of Stockholders on May 18, 2026 (record date March 30, 2026), proposing the election of 11 directors, an advisory vote to approve 2025 named executive officer compensation, amendment and restatement of the 2021 Stock Incentive Plan, adoption of the Employee Stock Purchase Plan, and ratification of KPMG LLP as independent auditors for the year ending December 31, 2026. The statement references the 2025 Annual Report on Form 10-K but provides no specific financial metrics or period-over-period comparisons in the excerpt. No declines, flat performance, or mixed results are highlighted as the focus is on governance matters.
- ·Annual Meeting: Monday, May 18, 2026, at 2:00 p.m. Pacific Time, virtual format via meetnow.global/MLUSZFD
- ·Proxy materials mailed on or about April 8, 2026; available at www.envisionreports.com/EWBC
- ·Fiscal year end: December 31
- ·Principal executive office: 135 N. Los Robles Ave., 7th Floor, Pasadena, CA 91101
08-04-2026
Consolidated Edison Inc's DEF 14A proxy statement for the 2026 Annual Meeting details strong corporate governance practices, including 10 of 11 independent directors (average age 65 with balanced tenure: 46% ≤6 years, 27% 7-16 years, 27% >16 years), an independent Lead Director, frequent executive sessions, and annual board self-assessments. Compensation policies emphasize pay-for-performance with 70% of 2025 long-term incentives performance-based and 30% time-based RSUs, alongside risk mitigation through balanced short- and long-term goals; proxy access and 25% ownership threshold for special meetings are also highlighted. No declines or flat metrics are disclosed in governance or compensation structure.
- ·Directors who are executive officers limited to one other public company board; others to no more than three; none exceeded in 2025.
- ·Voting: majority in uncontested elections, plurality in contested.
- ·Director terms: one-year, expiring at 2027 Annual Meeting.
- ·Corporate Governance and Nominating Committee oversees director nominations, diversity in candidate slates.
08-04-2026
First Watch Restaurant Group, Inc. (FWRG) filed its definitive proxy statement (DEF 14A) on April 8, 2026, for the virtual-only 2026 Annual Meeting of Stockholders on May 20, 2026, at 8:00 a.m. ET. Stockholders of record as of March 23, 2026, will vote on electing three Class II directors for three-year terms, advisory approval of named executive officer compensation (say-on-pay), frequency of future say-on-pay votes, and ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal 2026; no financial performance metrics or changes are highlighted in the filing.
- ·Annual Meeting webcast location: www.virtualshareholdermeeting.com/FWRG2026
- ·Fiscal 2025 ended December 28, 2025 (52-week year); fiscal 2026 ends December 27, 2026
08-04-2026
Ardent Health, Inc. (ARDT) has filed a definitive proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on May 20, 2026, at 9:00 a.m. Central Time. Key proposals include electing 11 director nominees, an advisory vote to approve named executive officer compensation, and ratification of Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2026. The record date is March 26, 2026, with 143,095,662 shares of common stock outstanding.
- ·Annual Meeting held solely by remote communication via live webcast at www.virtualshareholdermeeting.com/ARDT2026
- ·Voting prior to meeting available at www.proxyvote.com
- ·Company address: 340 Seven Springs Way, Suite 100, Brentwood, Tennessee 37027
- ·References 2025 Annual Report to Stockholders
08-04-2026
International Tower Hill Mines Ltd. (THM) has issued a proxy statement for its 2026 Annual General Meeting of Shareholders on May 27, 2026, to receive audited financial statements for the fiscal year ended December 31, 2025, fix the number of directors at seven, elect seven director nominees, appoint Davidson & Company LLP as auditors for 2026, and conduct advisory votes on named executive officer compensation and the frequency of such votes (recommending every one year). As of the record date April 8, 2026, there are 261,637,473 common shares outstanding, with quorum requiring holders of at least 5% of shares. No financial performance metrics are detailed in the filing.
- ·Record date: close of business on April 8, 2026.
- ·Quorum: two persons representing at least 5% of issued and outstanding Common Shares.
- ·Meeting location: offices of McCarthy Tetrault LLP, Suite 2400 - 745 Thurlow Street, Vancouver, BC; conference call access provided.
- ·Proxy materials first sent on or about April 17, 2026; available at www.ithmines.com.
08-04-2026
Option Care Health, Inc. highlighted strong 2025 performance in its 2026 Proxy Statement, including $5.65B net revenue (13% growth over FY24), $471.3M Adjusted EBITDA (6.2% growth), $1.72 Adjusted EPS (8.9% growth), $258M operating cash flow, and over $460M in investments. The proxy solicits votes for nine director nominees, ratification of KPMG LLP as auditors for 2026, and advisory approval of executive compensation at the May 20, 2026 annual meeting. Leadership updates include Meenal Sethna as new CFO succeeding Mike Shapiro, and the retirement of directors Elizabeth Q. Betten and David W. Golding post-meeting.
- ·Net Debt Leverage Ratio of 2.0x as of December 31, 2025
- ·Annual Meeting on May 20, 2026 at 2:00 p.m. CDT (virtual at www.virtualshareholdermeeting.com/OPCH2026)
- ·Record date: March 24, 2026
- ·Over 2.5 million infusion events in 2025
08-04-2026
LTC Properties, Inc. filed its DEF 14A Proxy Statement dated April 8, 2026, for the 2026 Annual Meeting of Stockholders on May 20, 2026 (record date March 23, 2026), seeking approval to elect six directors, approve named executive officer compensation on an advisory basis, and ratify Ernst & Young LLP as independent registered public accounting firm for fiscal 2026. As of December 31, 2025, the Board comprises six members, including five independent directors (Cornelia Cheng, David L. Gruber, Jeffery C. Hawken, Bradley J. Preber, Timothy J. Triche, MD) and Wendy L. Simpson as Executive Chairman. No specific financial performance metrics, period-over-period changes, or compensation amounts are detailed in the filing excerpt.
- ·Annual Meeting: Wednesday, May 20, 2026 at 5:00 p.m. Pacific Time, virtually at www.virtualshareholdermeeting.com/LTC2026
- ·Voting deadline: 11:59 p.m. Eastern Time on May 19, 2026
- ·Proxy materials available at http://materials.proxyvote.com/502175, including 2025 Annual Report
08-04-2026
Via Transportation, Inc. (VIA) filed a DEF 14A Proxy Statement on April 08, 2026. Stockholders of record on March 23, 2026 may request a free copy of the Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (excluding exhibits, for which a fee applies), addressed to Attention: Legal at 114 5th Ave, 17th Floor, New York, NY 10011. The 10-K is also accessible online at investors.ridewithvia.com.
- ·SEC CIK: 0001603015
- ·Fiscal year reference: 2025-01-01 to 2025-12-31
08-04-2026
Rexford Industrial Realty achieved solid 2025 results including $219.8M net income, 2.6% Core FFO per diluted share growth, 4.3% Same Property Portfolio Cash NOI growth, 10.4M square feet of leasing at 23.4% net effective spreads, 2.2M square feet stabilized across 21 projects with $798M invested generating $39M leased NOI, $218M dispositions, and $250M share repurchases while maintaining $1.4B liquidity and 4.4x net debt to Adjusted EBITDA. ESG progress included 100% employee inclusion training, 23 LEED certifications, 10.2 MW new solar, and 70% waste diversion. Michael Frankel and Howard Schwimmer will retire from the Board effective at the Annual Meeting, reducing Board size to seven with nominees including CEO Laura Clark and independent Chairman Tyler H. Rose.
- ·Net Debt to Adjusted EBITDAre of 4.4x as of 12/31/25
- ·Credit Ratings: BBB+/BBB+/Baa2 (S&P/Fitch/Moody’s)
- ·Reached out to stockholders representing 89% of common stock in 2025; met/spoke with 86%
- ·6 of 7 director nominees independent; Board reducing to 7 members post-retirements
- ·Prohibition of hedging and pledging by officers/directors; SEC/NYSE compliant clawback policy
08-04-2026
Installed Building Products, Inc. (IBP) issued its DEF 14A Proxy Statement dated April 8, 2026, for the 2026 Annual Meeting of Stockholders, seeking shareholder approval for the election of directors Michael T. Miller, Marchelle E. Moore, and Robert H. Schottenstein to three-year terms, ratification of Deloitte & Touche LLP as independent registered public accounting firm for 2026, and an advisory vote on named executive officer compensation. The document provides overviews of 2025 financial highlights (specific metrics not detailed), corporate responsibility initiatives, board composition and skills, director compensation, and executive compensation analysis including pay versus performance disclosures for fiscal years 2021-2025. No quantitative period-over-period changes or performance variances (positive, negative, or flat) are specified in the available content.
- ·Proxy materials available electronically; paper copies available upon request.
- ·Voting options: online at www.envisionreports.com/IBP, phone at 1-800-652-8683, mail proxy card, or at meeting via https://meetnow.global/MQFXVJC.
- ·Disclosures include Summary Compensation Table, Grants of Plan-Based Awards, Outstanding Equity Awards, Stock Vested, Pension Benefits, Non-Qualified Deferred Compensation, CEO Pay Ratio, and Pay Versus Performance for PEO and Non-PEO NEOs covering 2021-2025.
08-04-2026
Qnity Electronics, Inc. (NYSE: Q) filed its 2026 definitive Proxy Statement (DEF 14A) on April 8, 2026, for the virtual Annual Meeting of Stockholders on May 21, 2026 (record date March 25, 2026), proposing election of three Class I directors, advisory approval of named executive officer compensation ('Say on Pay'), frequency of future Say on Pay votes (every one year), and ratification of PricewaterhouseCoopers LLP as independent auditors for the year ending December 31, 2026. The statement highlights strong 2025 pro forma financial performance post-spin-off from DuPont, including net sales of $4.75B (10% growth), Adjusted Pro Forma Operating EBITDA of $1.4B (11% growth), and Adjusted Pro Forma EPS of $3.35 (12% growth), with Semiconductor Technologies segment net sales at $2.6B (up from $2.1B) and Adjusted Pro Forma Operating EBITDA at $932M (up from $534M). Qnity operates two segments—Semiconductor Technologies and Interconnect Solutions—with ~10,000 employees across ~40 global manufacturing sites.
- ·Annual Meeting: May 21, 2026 at 1:00 P.M. Eastern Time, virtual at www.virtualshareholdermeeting.com/Q2026
- ·Record date: March 25, 2026
- ·Serves 80+ countries and regions
- ·Americas: 19 plants, 7 labs, 2 offices; Asia-Pacific: 19 plants, 8 labs, 12 offices; Europe: 1 plant, 2 labs, 5 offices
- ·Headquarters: Wilmington, DE; Ticker: Q (NYSE)
08-04-2026
First Capital, Inc. will hold its 2026 annual shareholder meeting on May 18, 2026, at 12:00 noon local time at First Harrison Bank's Shepherdsville, Kentucky office to elect five directors for three-year terms, ratify Crowe LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, and conduct an advisory vote approving named executive officer compensation. The record date is March 26, 2026, with 3,345,531 shares of common stock outstanding, and shareholders are urged to vote via internet, telephone, or proxy card. The Board, consisting of 13 members (11 independent), recommends voting FOR all proposals.
- ·Record holders beneficially owning >10% of shares limited to 10% voting power per Articles of Incorporation.
- ·Proxy materials and 2025 Annual Report on Form 10-K available at http://www.edocumentview.com/FCAP.
- ·ESOP participants must direct voting instructions by May 11, 2026; undirect shares voted proportionally.
- ·Directors elected by plurality; ratification and say-on-pay require majority of votes cast; abstentions and broker non-votes have no effect.
08-04-2026
Americold Realty Trust (COLD) filed its DEF 14A proxy statement on April 8, 2026, providing pay versus performance disclosures for principal executive officers (PEOs) Robert S. Chambers, George F. Chappelle, and Fred Boehler across fiscal years 2021-2025. The filing details various compensation components including aggregate changes in pension values, equity awards, dividends on equity, and fair value adjustments for outstanding and unvested equity awards, with no specific numerical changes highlighted in the provided XBRL tags.
- ·Filing covers fiscal years 2021 through 2025
- ·Fred Boehler service period noted as 2021-01-01 to 2021-08-31
- ·XBRL tags include compensation elements such as pension adjustments, equity awards fair value changes, and vesting conditions
08-04-2026
Merck & Co., Inc.'s 2026 proxy statement details executive compensation adjustments via Pay vs. Performance disclosures for 2021-2025, featuring PEOs Mr. Davis and Mr. Frazier. The shareholder letter highlights 2025 achievements, including a projected $70B commercial opportunity from late-stage pipeline assets by mid-2030s (up $20B YoY), over 20 potential new growth drivers, and 80 ongoing Phase 3 studies. Key product milestones include FDA approvals for KEYTRUDA QLEX subcutaneous, WINREVAIR, OHTUVAYRE, ENFLONSIA, and positive data for WELIREG, sac-TMT (17 Phase 3 trials), enlicitide, and CAPVAXIVE.
- ·Annual shareholder meeting scheduled for May 26, 2026
- ·Proxy materials and 2025 10-K available at www.proxyvote.com
- ·Voting closes at 11:59 p.m. ET on May 25, 2026
08-04-2026
Rapid Micro Biosystems, Inc. (RPID) filed a definitive proxy statement (DEF 14A) for its 2026 Annual Meeting of Stockholders on May 21, 2026, to elect Richard Kollender as a Class II Director serving until the 2029 Annual Meeting and to ratify PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. The meeting will be held virtually, with Class A stockholders of record as of March 31, 2026 entitled to vote. No other matters are specified beyond potential adjournments.
- ·Annual Meeting conducted virtually via live webcast at www.virtualshareholdermeeting.com/RPID2026
- ·Proxy materials available online at www.proxyvote.com and investors.rapidmicrobio.com
- ·2025 Annual Report on Form 10-K available at investors.rapidmicrobio.com under 'Financial Information'
08-04-2026
Investar Holding Corporation's DEF 14A proxy statement, filed April 8, 2026, solicits votes for the 2026 Annual Meeting on May 20, 2026, including the election of 13 directors for one-year terms, ratification of BDO USA, P.C. as independent auditors for fiscal 2026, advisory approval of named executive officer compensation and frequency of future say-on-pay votes, and approval of the Second Amended and Restated 2017 Long-Term Incentive Compensation Plan. The record date for shareholders is March 23, 2026. No financial results or performance metrics are detailed in the provided materials.
- ·Annual Meeting time and place: 3:00 p.m. Central Time, Investar Tower, 10500 Coursey Boulevard, Third Floor, Baton Rouge, Louisiana 70816.
- ·Annual Report on Form 10-K for year ended December 31, 2025 available online at http://www.proxydocs.com/ISTR.
- ·Proxy materials first made available to shareholders on or about April 8, 2026.
08-04-2026
Sotera Health's 2026 DEF 14A proxy statement outlines non-employee director compensation policies, including $75,000 annual cash retainers plus committee chair premiums, and $225,000 target RSU grants, while seeking advisory 'say-on-pay' approval for NEO compensation following 99% stockholder support in 2025. For FY2025, the company achieved 5.7% revenue growth to $1.164 billion and 8.2% Adjusted EBITDA growth to $594 million, with Sterigenics up 8.3% and Nordion up 8.2%; however, Nelson Labs revenue declined 3.9%. AIP payouts reached 103% of target overall and 108% for Sterigenics, reflecting strong performance amid long-term incentive design changes incorporating PSUs and SAUs.
- ·Non-employee directors receive additional cash: $25,000 Audit chair, $20,000 LDC chair, $15,000 NCG chair, $40,000 Lead Independent Director, $25,000 special committee.
- ·Alexander Dimitrief retired effective March 31, 2026.
- ·2025 long-term incentives revised: >=50% performance-based with PSUs (3-year revenue/FCF), CEO SAUs (stock price goals), performance modifier on non-CEO RSUs.
- ·Adjusted EBITDA margin expanded 118 basis points to 51.0% in FY2025.
08-04-2026
CPI Card Group Inc.'s definitive proxy statement for the virtual 2026 Annual Meeting on May 21, 2026 seeks re-election of eight directors, ratification of KPMG LLP as 2026 auditors, and an advisory vote on named executive officer compensation, with a record date of March 24, 2026. Major shareholders include Tricor entities holding 19.0% of the 11,458,988 outstanding shares, while directors and executives beneficially own 5.8% in aggregate. Recent Q1 2026 management transitions feature Jeffrey Hochstadt transitioning out of the CFO role, Terra Grantham as Interim CFO, and promotions for Peggy O’Leary, Toni Thompson, Rob Dixon, and Ernesto Boada.
- ·Two delinquent Section 16(a) reports: one Form 4 by Parallel49 and one Form 3 by Tricor Family Office, filed late.
- ·Each non-employee director has 6,739 outstanding RSUs as of December 31, 2025; effective January 1, 2024, they may elect to defer as DSUs.
- ·John Lowe beneficial ownership includes 87,580 options and 11,262 RSUs.
08-04-2026
Fold Holdings, Inc. reported strong 2025 performance despite a challenging macro environment with bitcoin shedding significant market cap, achieving $31.8 million in revenue (up 34% YoY) and $960 million in transaction volume (up 46% YoY). The company strengthened its balance sheet by eliminating $66.3 million in convertible debt and holds 827 bitcoin in treasury as of March 17, 2026. This proxy statement seeks shareholder approval to elect two Class I directors and ratify CBIZ CPAs P.C. as auditors for fiscal 2026 at the annual meeting on May 19, 2026.
- ·Annual Meeting: May 19, 2026 at 12:00 ET virtually at www.virtualshareholdermeeting.com/FLD2026
- ·Record Date: March 24, 2026
- ·Proposals: Elect two Class I directors for term until 2029; Ratify CBIZ CPAs P.C. for FY ending Dec 31, 2026
- ·First full year as public company in 2025; services available in all 50 states
08-04-2026
Karman Holdings Inc. (KRMN) has issued a definitive proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on April 29, 2026 at 9:00 a.m. Pacific Time, with the sole proposal being the election of two Class I director nominees, Mary Petryszyn and Stephen Twitty, each to serve until the 2029 annual meeting. The record date is March 5, 2026, with 132,526,299 shares of common stock outstanding entitled to vote; the Board recommends voting FOR both nominees under a plurality voting standard.
- ·Annual Meeting held exclusively virtually via live webcast at www.virtualshareholdermeeting.com/KRMN2026.
- ·Quorum requires majority of voting power of outstanding shares present virtually or by proxy.
- ·Proposal is non-routine; broker non-votes and withheld votes have no effect on election outcome.
- ·Proxy materials, including 2025 Form 10-K, mailed or emailed on or about April 8, 2026.
08-04-2026
Global Medical REIT Inc. (GMRE-PB) filed a DEF 14A proxy statement on April 08, 2026, for its annual stockholder meeting, proposing the election of six director nominees (Jeffrey M. Busch, Matthew Cypher, Mark Decker, Jr., Zhang Huiqi, Paula R. Crowley, Lori Wittman), an advisory vote to approve named executive officer compensation, an amendment to the 2016 Equity Incentive Plan extending its term to May 20, 2036 and increasing reserved shares by 300,000, and ratification of Deloitte & Touche LLP as independent auditors for the year ending December 31, 2026. The Board of Directors recommends voting 'FOR' all main proposals. No financial performance data, compensation figures, or period-over-period comparisons are provided in the filing excerpt.
- ·Proxy available at: https://web.viewproxy.com/XRN/2026
- ·Annual meeting to consider other business as may properly come before it or any adjournments
08-04-2026
Galaxy Digital Inc. will hold its 2026 Annual Meeting of Stockholders virtually on May 28, 2026 at 9:00 a.m. ET to elect six directors (Michael Daffey, Bill Koutsouras, Rhonda Adams-Medina, Douglas Deason, Jane Dietze, and Michael Novogratz), ratify KPMG LLP as independent auditors for FY 2026, approve advisory vote on Named Executive Officer compensation, and select frequency of future comp votes (Board recommends every one year). The proxy highlights strong governance including a non-classified Board, Lead Independent Director, and stock ownership guidelines for non-employee directors. This follows May 2025 Reorganization Transactions domesticalizing to Delaware.
- ·Record date: April 2, 2026
- ·Virtual meeting URL: www.virtualshareholdermeeting.com/GLXY2026
- ·Proxy materials mailed on or about April 8, 2026
- ·Annual Report on Form 10-K for year ended December 31, 2025 available at www.proxyvote.com
08-04-2026
Topgolf Callaway Brands Corp. (MODG), referred to as Callaway Golf Company in the proxy, filed its DEF 14A Proxy Statement on April 8, 2026, for the virtual-only 2026 Annual Meeting of Shareholders on May 21, 2026, at 11:00 a.m. ET. Shareholders are asked to elect nine director nominees, ratify Deloitte & Touche LLP as independent auditors for the fiscal year ending December 31, 2026, and approve named executive officer compensation on an advisory basis, with a record date of March 30, 2026. No financial performance metrics or period-over-period comparisons are detailed in the provided filing content.
- ·Annual Meeting held virtually at www.meetnow.global/MH5W7PK.
- ·Record date for shareholders: March 30, 2026.
- ·Proxy materials first made available on or about April 8, 2026.
- ·XBRL tags indicate disclosure of PEO and Non-PEO NEO equity compensation metrics for fiscal years 2021-2025, including equity awards, year-end values, changes in fair value, vesting, and dividends, though specific numerical values not provided in excerpt.
08-04-2026
Pyrophyte Acquisition Corp., a SPAC, is holding an Extraordinary General Meeting on April 28, 2026, to vote on extending its initial business combination deadline from April 29, 2026, to April 29, 2027, to provide more time for its proposed Sio Business Combination with Sio Silica Corporation, which has already undergone five amendments due to delays including a February 2024 permit denial for the Vivian project. The board unanimously recommends approval, with sponsor Pyrophyte Acquisition LLC committing up to $908,376 in contributions at $0.05 per remaining public share, while the Trust Account holds $19,215,495.44 offering $12.69 per share redemption amid trading prices of $15.43 for shares. However, repeated extensions highlight ongoing execution risks and potential for further delays or liquidation if the deal fails.
- ·Redemption requests must be submitted by 5:00 p.m. ET on April 24, 2026, to Continental Stock Transfer & Trust Company.
- ·Business Combination Agreement originally dated November 13, 2023, with amendments on November 12, 2024; December 31, 2024; April 11, 2025; October 16, 2025; and March 13, 2026.
- ·Sio’s initial permit application for Vivian project denied by Manitoba government on February 16, 2024.
- ·IPO consummated on October 29, 2021.
- ·Fourth Extension Contributions conditioned on Extension approval and deposited into Trust Account, evidenced by non-interest-bearing promissory note repayable upon business combination.
08-04-2026
Middleby Corp's 2026 Proxy Statement outlines the Annual Meeting on May 19, 2026, to elect 11 directors, approve NEO compensation on an advisory basis, and ratify Ernst & Young LLP as auditors. Key highlights include the February 2026 divestiture of a majority interest in the residential kitchen equipment business, yielding $565M in net cash proceeds and a $135M promissory note while retaining a 49% stake, as part of portfolio transformation to a pure-play commercial foodservice company. The Board expanded with four new directors since 2024, enhancing expertise in growth, strategy, and cybersecurity.
- ·Annual Meeting record date: March 20, 2026
- ·Fiscal year ended January 3, 2026
- ·Virtual meeting at www.virtualshareholdermeeting.com/MIDD2026
- ·Added two new directors in 2026 (Glenn A. Eisenberg, Christopher M. Hix), two in 2025, and two in 2024
- ·Audit Committee oversees cybersecurity program with periodic updates
08-04-2026
TPG RE Finance Trust, Inc. filed a DEF 14A proxy statement disclosing 2025 equity-based compensation for named executive officers (NEOs), including restricted stock unit (RSU) grants with grant date fair values totaling $6,694,896 across Doug Bouquard ($3,915,423), Matthew Coleman ($515,599), Brandon Fox ($236,860), and Robert Foley ($1,026,014). At December 31, 2025, outstanding unvested RSUs held by NEOs had an aggregate market value of $13,299,946, calculated at $8.61 per share. In 2025, RSUs vesting for NEOs realized $4,000,000 in value at $7.72 per share on June 30, with no cash compensation, pensions, or deferred comp reported.
- ·RSUs generally vest ratably in four annual installments beginning June 30 following grant date.
- ·Robert Foley retired as CFO on Oct 1 2025 and from TPG on Dec 31 2025; his RSUs continue vesting per retirement terms.
- ·No pension benefits or nonqualified deferred compensation provided to NEOs.
- ·No payments or accelerated vesting upon change in control except for qualifying terminations (Type I Leaver, disability, death).
- ·NEOs are employees of the Manager or affiliates; no direct cash compensation from the Company.
08-04-2026
Hyperfine, Inc. (HYPR) has issued a DEF 14A proxy statement for its 2026 virtual annual meeting on May 21, 2026, at 10:00 a.m. ET, to elect directors and ratify Grant Thornton LLP as independent auditors for the fiscal year ending December 31, 2026. As of the record date March 25, 2026, 98,520,197 shares of common stock were outstanding, comprising 83,464,909 Class A shares (1 vote each) and 15,055,288 Class B shares (20 votes each). No financial performance metrics or period comparisons are provided in the filing.
- ·Annual meeting voting deadline: 11:59 p.m. ET on May 20, 2026
- ·Virtual meeting access: www.virtualshareholdermeeting.com/HYPR2026 with 16-digit control number
- ·References Annual Report on Form 10-K for fiscal year ended December 31, 2025
08-04-2026
Bloom Energy Corp's 2026 Proxy Statement seeks stockholder approval for the election of four Class II directors, a non-binding advisory vote on 2025 named executive officer compensation, ratification of Deloitte as independent auditor, and amendments to the Restated Certificate of Incorporation for officer exculpation and removal of outdated Class B common stock references. The document highlights the company's strategy to scale solid oxide fuel cell technology for onsite power in AI data centers, advanced manufacturing, and critical infrastructure amid rising electricity demand. No specific financial performance metrics or period-over-period changes are detailed in the provided content.
- ·Annual stockholder meeting voting roadmap recommends 'FOR' all five proposals.
- ·References to unaudited reconciliations from GAAP to Non-GAAP in Appendix A.
- ·Pay Versus Performance Table and detailed compensation tables (e.g., 2025 Summary Compensation Table) included for fiscal years 2023-2025.
08-04-2026
Granite Ridge Resources, Inc. filed its DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders, to be held virtually on May 22, 2026, at 10 a.m. Central Time. Key proposals include electing three Class I director nominees to serve until the 2029 annual meeting, ratifying Forvis Mazars, LLP as independent auditors for the fiscal year ending December 31, 2026, advisory votes on named executive officer compensation and vote frequency (Board recommends every year), and approving an increase of 2,500,000 shares authorized under the 2022 Omnibus Incentive Plan with a two-year extension. The record date for voting eligibility is March 24, 2026.
- ·Meeting hosted virtually at https://www.cstproxy.com/graniteridge/2026
- ·Board fixed March 24, 2026 as record date
- ·Proxy materials and 2025 Annual Report available at https://ir.graniteridge.com
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
🇺🇸 More from United States
View all →April 01, 2026
US Pre-Market SEC Filings Roundup — April 01, 2026
US Pre-Market SEC Filings Roundup
April 01, 2026
Dow Jones 30 Stocks SEC Filings — April 01, 2026
Dow Jones 30 Stocks SEC Filings
April 01, 2026
S&P 500 Consumer Discretionary Sector SEC Filings — April 01, 2026
S&P 500 Consumer Discretionary Sector SEC Filings
April 01, 2026
S&P 500 Healthcare Sector SEC Filings — April 01, 2026
S&P 500 Healthcare Sector SEC Filings